Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects
Clinical trial NCT05594615 · COMPLETED
Trial details
- NCT number
- NCT05594615
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2022-11-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.